Current Chronic Hepatitis News and Events | Page 25

Current Chronic Hepatitis News and Events, Chronic Hepatitis News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
Mayo clinic: Long-term benefits to the liver-kidney transplant
A new study from physicians at Mayo Clinic in Rochester, found there may be long-term benefits to simultaneous liver-kidney transplantation versus kidney transplantation alone. (2016-04-15)

Treating patients for hepatitis C could reduce the need for liver transplants
A new study presented today demonstrates that patients on the liver transplant list with hepatitis C virus (HCV) and severe liver damage were more likely to be taken off the list or have their need of a liver transplant reduced as a result of direct-acting antiviral therapy. (2016-04-14)

'Risk' genes heighten the chances of heavy drinkers developing alcoholic hepatitis
New research presented today at The International Liver Congress™ 2016 in Barcelona, Spain has uncovered a genetic link that explains why certain people with alcohol dependence are more susceptible to developing severe alcoholic hepatitis. (2016-04-14)

New triple drug combination shows promise in hepatitis C infected patients
New data presented today at The International Liver Congress™ 2016 in Barcelona, Spain, demonstrates a high sustained virologic response (SVR) at 12 weeks from the all-oral combination of sofosbuvir/velpatasvir and experimental compound GS-9857 in patients with the hepatitis C virus (HCV). (2016-04-14)

Study raises questions about the risks of treating patients with late stage hep C virus
New data presented today raise the question of whether patients with severe hepatitis C virus (HCV) should be treated with direct-acting antivirals (DAAs), given their high risk of short-term death at this late-disease stage. (2016-04-14)

Study demonstrates the potential for a new triple combination treatment for hepatitis C patients
A new combination treatment for hepatitis C has potential for patients who were not cured by current treatment options. (2016-04-14)

Newly approved all-oral hep C combination drug found more effective in head-to-head comparison
Findings presented today from a Phase 3 head-to-head study that compared two direct-acting antiviral treatment regimens, demonstrated that the all-oral, once daily combination of elbasvir and grazoprevir was more effective and safer than the combination of sofosbuvir and pegylated interferon with ribavirin, in certain patients with hepatitis C. (2016-04-14)

DNDi and Pharco to test affordable hepatitis C regimen with Malaysian and Thai governments
The Drugs for Neglected Diseases initiative and the Egyptian drug manufacturer Pharco Pharmaceuticals have signed agreements covering the clinical testing and scale-up of a hepatitis C treatment regimen at a price of just under $300. (2016-04-13)

High rate of cancer recurrence found in certain hepatitis C patients
Data from a new study show that patients with hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer had a 'high rate' of re-developing their illness. (2016-04-13)

Community-based treatment providers can help ease pressure on specialists in battle against hep C
A new study, presented today, demonstrates treatment for hepatitis C can be provided safely and effectively within a community-based and non-specialist setting. This illustrates the potential for alternative providers to ease pressure on currently overburdened specialists. The study, sponsored by the National Institutes of Health, was presented at The International Liver Congress™ 2016 in Barcelona, Spain. (2016-04-13)

Researchers open the way to new treatments for chronic pain and cancer
In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length structure of a protein named Transient Receptor Potential Vanilloid subtype 2 (TRPV2). Taken in addition to their study of its molecular mechanism last year, Dr. Vera Moiseenkova-Bell's laboratory has revealed TRPV2 as new target for pharmaceutical research treating chronic pain and cancer. (2016-04-13)

People with hepatitis C are two to five times more likely to develop certain head and neck cancers
Long associated with liver cancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus is associated with certain head and neck cancers. (2016-04-13)

Differing perspectives on antiviral treatment efficacy in patients co-infected with HIV and HCV
Two separate studies presented today at The International Liver Congress™ 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and hepatitis C virus (HCV). (2016-04-13)

The Miriam Hospital receives NIH grant to study benefits of stress management for chronic diseases
The Miriam Hospital's Centers for Behavioral and Preventive Medicine received a $464,465 grant from the National Center for Complementary and Integrative Health of the National Institutes of Health to enable researchers to conduct a comprehensive, four-year study on the benefits of stress management interventions for chronic pain and illness. (2016-04-12)

New report: Hepatitis B and C could be eliminated as public health problems in US
It is possible to end the transmission of hepatitis B and C and prevent further sickness and deaths from the diseases, but time, considerable resources, and attention to various barriers will be required, says a new report from the National Academies of Sciences, Engineering, and Medicine. (2016-04-11)

Heavy drinking endangers the health of liver transplants
Alcoholic liver disease is a major indication for liver transplantation, but up to 20 percent of patients experience severe alcoholic relapse. New research shows that such relapse can cause significant damage to newly transplanted livers. (2016-04-07)

Factors associated with good heart health may also protect kidneys
Middle-aged adults who scored well on the American Heart Association's Life's Simple 7 checklist were less likely to develop chronic kidney disease than those with low scores. Not smoking, maintaining a healthy weight, exercising, blood pressure control and having healthy blood sugar levels were all associated with a lower risk of chronic kidney disease. (2016-04-06)

Cannabis use in pregnancy linked to low birthweight and intensive care
Use of cannabis during pregnancy is linked to low birthweight and the need for intensive care, reveals an analysis of the available evidence, published in the online journal BMJ Open. (2016-04-05)

Survivorship improving for acute liver failure patients, 16-year analysis led
More patients hospitalized with acute liver failure -- often the result of acetaminophen overdose -- are surviving, including those who receive a liver transplant and those who don't, an analysis led by a UT Southwestern Medical Center researcher showed. (2016-04-04)

Researcher finds potential new source for pain inhibition
A UT Dallas scientist has found a new neurological mechanism that appears to contribute to a reduction in pain. According to Dr. Ted Price, associate professor in the School of Behavioral and Brain Sciences, the discovery of neuroligin-2 as a cause exacerbating chronic pain is significant for the research community. Although the findings likely won't immediately lead to new pain therapies, the findings offer a potential new therapeutic direction to investigate. (2016-04-04)

New test can predict death in patients with serious liver disease
Researchers from Aarhus University Hospital and Aarhus University in Denmark have found that the biomarker CD163 can predict mortality in blood samples from patients with acute on chronic liver failure. (2016-04-01)

Infections of the heart with common viruses
Virus infections of the heart are a significant cause of sudden unexpected death due to cardiovascular reasons in young men and also produce chronic cardiomyopathy which frequently requires heart transplantation. The review in the journal Current Pharmaceutical Design provides current updates on our understanding of how virus infection and the body's immune response to that infection result in heart injury. (2016-03-31)

Kidney disease: Report assesses mammoth problem for the United States
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the US population and costs billions in Medicare spending each year. (2016-03-29)

IUPUI researcher to study cause of chronic post-traumatic headaches
An assistant professor in the Department of Kinesiology in the IU School of Physical Education and Tourism Management at Indiana University-Purdue University Indianapolis has been awarded a grant to study the role of deficient pain modulatory systems on chronic post-traumatic headaches afflicting hundreds of thousands of people with mild traumatic brain injuries. (2016-03-29)

Uric acid, gout and kidney disease: The chicken or the egg?
The increasing prevalence of both gout and chronic kidney disease has led to a growing interest in the association between hyperuricemia (an abnormally high level of uric acid in the blood) and kidney disease. (2016-03-28)

Leading global health commission calls for reform of drug policies worldwide
A leading global public health commission is calling for new policies that would transform our approach to drug use, addiction and control worldwide, including the decriminalization of minor and non-violent drug offenses. (2016-03-24)

The Lancet: Experts call for global drug policy reform as evidence shows 'war on drugs' has harmed public health and human rights
Fifty years of drug policies aimed at restricting and criminalizing drug use and minor possession have had serious detrimental effects on the health, well-being and human rights of drug users and the wider public, according to a major new report by The Lancet and Johns Hopkins University in the US. (2016-03-24)

Paradigm shift: 'We need to study lumps of bacteria'
New research from the University of Copenhagen reveals that bacteria which agglutinate before entering the body are far more resistant than single-celled bacteria. This may be the cause of chronic infections. (2016-03-23)

Chronic diseases may negatively affect the mental health of poor and middle-income adults
In a study of more than 8,000 adults, those with a chronic health condition such as diabetes or asthma were more likely to report psychological distress and functional impairment if they were residents of poor or middle-income households. (2016-03-23)

Use of mindfulness-based stress reduction for chronic low back pain
Among adults with chronic low back pain, both mindfulness-based stress reduction and cognitive behavioral therapy resulted in greater improvement in back pain and functional limitations when compared with usual care, according to a study appearing in the March 22/29 issue of JAMA. (2016-03-22)

More cost-effective cure for hepatitis C may be close
The cost of treating hepatitis C virus could be cut up to 50 percent if mathematical models are used to predict when patients can safely stop taking direct-acting antiviral medication, according to a new study by researchers at Loyola University Health System and Loyola University Chicago. (2016-03-22)

Transplant drug helpful for patients with progressive liver condition
New research indicates that mycophenolate mofetil, a drug that is usually used to prevent rejection after kidney, heart or liver transplant, seems safe and effective in treating autoimmune hepatitis, a serious chronic liver disease that mainly affects women. (2016-03-21)

Study shows spinal cord stimulation reduces emotional aspect of chronic pain
Researchers at The Ohio State University Wexner Medical Center have shown that patients with chronic pain can reduce their emotional response to the pain through spinal cord stimulation. (2016-03-17)

$3.8M grant awarded to surgeon to test transplant drug
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company. (2016-03-16)

Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends. A team led by researchers from UNIGE discovered how our cells defend themselves against HBV infection, but also how the virus fights back. This work represents an important advance in our understanding of HBV and suggests new avenues for the development of innovative therapeutic agents. (2016-03-16)

New research highlights need to give greater consideration to sleep in stroke care
Latest findings from the University of Surrey and University of Freiburg all point towards the important role of sleep in patients with stroke. However, at present, sleep is rarely considered in in-patient and community-based stroke care. The team of researchers also found that this is despite a number of studies that highlights patients with stroke often experience difficulties with their sleep. (2016-03-15)

Revamped LDN site launched -- biggest patient-initiated drug discovery program in history
LDN information site revamped. LDN is the biggest patient-initiated drug discovery program in history. LDN research to date encompasses 14 clinical trials and 19 case reports/series, including diseases such as Crohn's, Parkinson's, MS, fibromyalgia and HIV. The number of LDN users worldwide has now reached 300,000 and this has been achieved without any commercial sponsorship. (2016-03-15)

A how-to guide to prescribing exercise for chronic health conditions
Exercise helps to alleviate the symptoms of many chronic health conditions such as knee osteoarthritis, low back pain, chronic obstructive pulmonary disease (COPD), diabetes, heart disease and more, yet it is often overlooked as a treatment. A review in Canadian Medical Association Journal aims to provide an easy-to-use how-to guide for health care professionals to prescribe exercise for specific chronic diseases. (2016-03-14)

The role of organic transporters in pharmacokinetics and nephrotoxicity of newer antiviral therapies
Highly active antiretroviral therapy and direct acting antiviral agents are key elements in the effective pharmacotherapy of human immunodeficiency virus and Hepatitis C virus respectively. (2016-03-14)

Research to focus on chronic pain care, informed consent for patient records
An Indiana University-Purdue University Indianapolis researcher has been awarded $1.1 million to develop information-based tools to help primary care providers improve care for patients with chronic pain, a condition that affects 100 million Americans at a cost of $630 billion annually in health care costs and lost worker productivity. (2016-03-09)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to